Pharmaceutical News and Articles

U.S. FDA Approves Kerendia (finerenone) to Treat Patients with Heart Failure with Left Ventricular Ejection Fraction ≥40% Following Priority Review

Sugar, Sweeteners Might Trigger Early Puberty In Some Kids

MONDAY, July 14, 2025 Sugar and artificial sweeteners might increase the risk of early puberty in children, a new study says. Sugar, aspartame (Equal), sucralos

New Bride Survived Removal Of A 40-Pound Tumor

MONDAY, July 14, 2025 A young woman became a June bride months after surviving complex surgery to remove a 40-pound tumor from her body, Cedars-Sinai doctors re

Household Mold Can Trigger Lung Disease

MONDAY, July 14, 2025 Household mold can be a significant trigger for a rare but potentially debilitating lung disease that can cause permanent breathing proble

Diet Influences Constipation Risk, Study Says

MONDAY, July 14, 2025 Worried about maintaining your regularity as you grow older Changing your diet can reduce the risk of chronic constipation in middle-aged

Arizona Resident Dies From Pneumonic Plague

MONDAY, July 14, 2025 An Arizona resident has died from pneumonic plague, a rare but serious illness, health officials confirmed. The death happened in Coconino

FDA Approves Updated Label for Lilly's Kisunla (donanemab-azbt) with New Dosing in Early Symptomatic Alzheimer's Disease

How to Stay Safe at the Beach or Pool This Summer

SUNDAY, July 13, 2025 A day at the beach or pool is a great way to beat the summer heat but it can also be risky if you re not careful. Dr. Eric Costanzo of Hac

Killer Whales Show a Softer Side, Sharing Food With People

SATURDAY, July 12, 2025 They re known as killer whales, but orcas have a surprisingly soft and even generous side. Orcas often share food with each other it s a

FDA Grants Fast Track Designation for TRE-515 in Combination with Radiation Therapy for the Treatment of Metastatic Castration Resistant Prostate Cancer

Los Angeles, July 9, 2025 Trethera Corporation ( Trethera ), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoi